| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0015300 | Exon-Exon | chr10:31676053-31810864 | chr10:31387124-31521936 | 2689 nt | 0.4299 |
| hsa_ZEB1_0016300 | Exon-Exon | chr10:31676143-31676694 | chr10:31387214-31387765 | 99 nt | 0.4242 |
| hsa_ZEB1_0016400 | Intron-Exon-Intron | chr10:31676649-31677801 | chr10:31387720-31388872 | 1153 nt | 0.2975 |
| hsa_ZEB1_0016500 | Intron-Intron | chr10:31676941-31678396 | chr10:31388012-31389467 | 1456 nt | 0.2981 |
| hsa_ZEB1_0016600 | Intron-Intron | chr10:31691991-31692384 | chr10:31403062-31403455 | 394 nt | 0.3147 |
| hsa_ZEB1_0016700 | Intron-Intron | chr10:31706886-31707931 | chr10:31417957-31419002 | 1046 nt | 0.3881 |
| hsa_ZEB1_0016800 | Intron-Intron | chr10:31709626-31710079 | chr10:31420697-31421150 | 454 nt | 0.3965 |
| hsa_ZEB1_0016900 | Intron-Intron | chr10:31710037-31729537 | chr10:31421108-31440608 | 250 nt | 0.3720 |
| hsa_ZEB1_0017000 | Intron-Intron | chr10:31716546-31718900 | chr10:31427617-31429971 | 2355 nt | 0.3996 |
| hsa_ZEB1_0017100 | Intron-Intron | chr10:31724510-31724650 | chr10:31435581-31435721 | 141 nt | 0.4397 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].